APIMEDS PHARMACEUTICALS US, INC. Crypto Asset Realized And Unrealized Loss Operating
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Crypto Asset Realized And Unrealized Loss Operating of $13.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Goodwill and Other
us-gaap:CryptoAssetRealizedAndUnrealizedLossOperating · last filed 2026-08-14
- APIMEDS PHARMACEUTICALS US, INC. crypto asset realized and unrealized loss operating for the quarter ending 2026-06-30 was $13.18M.
| Period end | Crypto Asset Realized And Unrealized Loss Operating 3 month | Crypto Asset Realized And Unrealized Loss Operating 6 month |
|---|---|---|
| 2026-06-30 | $13.18M 10-Q · filed 2026-08-14 | $35.26M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |